Jeremy Rudy, founder of the Sabba Collective, explains how psychedelic therapy can be integrated into society safely and responsibly — from education to policy.

Senator Jeff Steinborn is the sponsor of the Medical Psilocybin Act in New Mexico, a visionary step toward expanding access to psychedelic therapy. In this conversation, filmed at the Psychedelic Science 2025 conference in Denver, he discusses why legislative action was necessary, how to ensure inclusion for marginalized communities, and what benchmarks will define success as New Mexico opens its first healing centers.

Charlotte James is a medicine woman, educator, and founder of the Psychedelic Liberation training. With Afro-Caribbean and Germanic ancestry, her work weaves together ancestral healing, social justice, embodiment, and plant medicine. In our conversation, she speaks about liberation, informed care, the power of ritual, and how to bring accountability and integrity into psychedelic spaces.

Psychedelic therapy can offer spiritual validation and gender euphoria for trans and non-binary people — Jae Sevelius explains what truly affirming psychedelic care means in practice.

Colorado is the second U.S. state to legalize the therapeutic use of psilocybin mushrooms. During the Psychedelic Science conference in June 2025, Drugreporter visited ETC Hospitality in Golden, Colorado — a newly licensed natural medicine healing center — to see how psilocybin-assisted psychotherapy will be practiced in real-world settings.

Clinical psychologist Brian Richards, Psy.D., explains how psychedelics can transform palliative care—from creating truly healing therapeutic spaces to supporting patients facing the end of life.

Two spiritual leaders from different faiths reveal how psychedelics are transforming their understanding of religion, community, and each other — watch Drugreporter’s new interview!

In Drugreporter’s new interview, trauma expert Bessel van der Kolk, MD explores how the body stores trauma and why integration is essential for healing in psychedelic therapy.

In Drugreporter’s new interview, Dominique Mendiola, Senior Director of Colorado’s Natural Medicine Division, shares how Colorado is shaping the next chapter of psychedelic regulation in the United States.

In Drugreporter’s new interview, Bill Richards, a pioneering psychologist and theologian who has explored the therapeutic and spiritual dimensions of psychedelics since the 1960s, reflects on the rebirth of psychedelic research and the enduring healing power of mystical experience.